TC BioPharm

/TC BioPharm

Follow-on

TC BioPharm

Biopharmaceutical

TCB based in Scotland, is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled TCB to develop a range of clinical-stage cell therapies designed to combat identified cancers and viral infections.

Symbol

TCBP

Last Closing Price
$1.08

Shares
6,956,522

Anticipated Date
May 26, 2022

Underwriters
EF Hutton

This offering is no longer available

To view the prospectus for TC BioPharm, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange